colorectal cancer

Swiss pharmaceutical giant Roche has struck a deal with Aileron Therapeutics worth up to $1.1 billion to gain access to a new class of drugs called stapled peptide therapeutics. This could yield new ways to attack hard-to-reach disease targets.

Cancer killed fewer Europeans in the first half of this decade, largely thanks to a decrease in smoking. A new study finds that while death rates from cancer varied between men and women and among countries, they generally improved in all major European nations. The study, published Monday in the...